Southwick G J, Temple-Smith P D
Department of Anatomy, Monash University, Clayton, Victoria, Australia.
Microsurgery. 1988;9(4):266-77. doi: 10.1002/micr.1920090412.
Surgical treatment for obstructive azoospermia was introduced about 30 years ago with the development of Bayle's vasoepididymal fistula technique (Bayle: Enc Med Chir 41:435, 1966). More recently this has been replaced by single tubule end-to-end microvasoepididymal bypass procedures with improved success rates. We describe the use of animal models in the development and application of a modified end-to-end microanastomosis technique in which the vas deferens is attached to a single surface convolution of the ductus epididymidis. In comparison with other microvasoepididymostomy (micro-VE) procedures, this technique results in less postoperative scarring and allows for easier access to the epididymis in those patients requiring subsequent epididymal surgery. With this procedure 60% of patients produced spermatozoa after operation, and 10% of 102 patients have so far achieved pregnancies. For patients, such as those with congenital absence of the vasa deferentia, whose infertility cannot be corrected by microvasoepididymal surgery, we describe a microaspiration procedure that can be used to collect spermatozoa from the epididymis for use in in vitro fertilization (IVF). This procedure has a low success rate at present, with an 18% fertilization and 3% pregnancy rate per cycle. Improvements in treatment procedures for aspirated sperm samples, such as the use of motility stimulators and in vitro maturation by coculture with epididymal tubule segments before IVF, may enhance the success for this technique. Microinjection of sperm collected by epididymal microaspiration into oocytes may be an alternative method of treatment for these patients in the future. Two procedures (microepididymoepididymostomy and the vas bridge bypass) that are currently being modelled in the rabbit may provide new directions for epididymal microsurgery and for examining epididymal function. Although the two methods are technically more difficult than standard micro-VE procedures, preliminary studies are encouraging and suggest a future role for these techniques in treating obstructive azoospermia. Such techniques make use of the epididymis distal to the obstruction site and may be particularly important in improving the success of surgery for obstructive azoospermic patients with high-level obstructions in whom sperm quality following micro-VE surgery is often poor.
大约30年前,随着贝勒氏输精管附睾瘘技术(贝勒:《医学与外科学百科全书》41:435,1966年)的发展,梗阻性无精子症的外科治疗被引入。最近,这种方法已被成功率更高的单管端端显微输精管附睾旁路手术所取代。我们描述了动物模型在一种改良的端端显微吻合技术的开发和应用中的使用,该技术将输精管连接到附睾管的单个表面卷曲处。与其他显微输精管附睾吻合术(显微-VE)相比,该技术术后瘢痕形成较少,并且在那些需要后续附睾手术的患者中更容易接近附睾。通过该手术,60%的患者术后产生了精子,到目前为止,102例患者中有10%已成功怀孕。对于那些不育症无法通过显微输精管附睾手术纠正的患者,如先天性输精管缺如患者,我们描述了一种显微抽吸程序,可用于从附睾中收集精子用于体外受精(IVF)。目前该程序的成功率较低,每个周期的受精率为18%,妊娠率为3%。对抽吸精子样本治疗程序的改进,如在IVF前使用活力刺激剂和与附睾管段共培养进行体外成熟,可能会提高该技术的成功率。将通过附睾显微抽吸收集的精子显微注射到卵母细胞中可能是未来这些患者的一种替代治疗方法。目前正在兔子身上模拟的两种手术(显微附睾附睾吻合术和输精管桥旁路术)可能为附睾显微手术和检查附睾功能提供新的方向。尽管这两种方法在技术上比标准的显微-VE手术更困难,但初步研究令人鼓舞,并表明这些技术在治疗梗阻性无精子症方面具有未来应用价值。此类技术利用梗阻部位远端的附睾,对于改善梗阻性无精子症患者的手术成功率可能尤为重要,这些患者存在高位梗阻,显微-VE手术后精子质量往往较差。